Connect with us

Hi, what are you looking for?

Alive Business PlanAlive Business Plan

Stock

Barclays bullish on Partners Group, upgrades to ‘overweight’

Investing.com — Barclays (LON:BARC) has upgraded Partners Group to “overweight,” reflecting increased confidence in its outlook for 2025, in a note dated Thursday.

This decision reflects Partners Group’s unique positioning among European private capital managers, particularly its exposure to the healthier U.S. market.

European alternative asset managers have lagged behind their U.S. counterparts, with valuations seeing a sharp divergence over the past year.

While U.S. private capital firms enjoyed robust share price gains and re-ratings, European firms largely traded sideways, leading to a valuation gap.

Partners Group stands out within this group, trading at 40% below its peak valuation while its U.S. peers remain within 15% of their highs.

Barclays sees this as an opportunity for revaluation, particularly given Partners’ alignment with the U.S.-centric market dynamics.

Key factors contributing to Barclays’ upgrade include Partners Group’s portfolio exposure, with 45% of its assets under management tied to the U.S., the highest among European peers.

This aligns with expectations of increased transactional activity in the U.S., supported by a favorable macroeconomic and political backdrop.

Additionally, Partners’ foothold in U.S. private wealth is a critical driver. Its private wealth AUM in North America accounts for 55% of its regional total and 42% of its evergreen product AUM, underscoring its dominance in this high-growth segment.

Fundraising and performance fee dynamics also play a role in this reassessment. While 2024 saw underwhelming performance fees across the sector due to muted exit activity, Partners Group is well-positioned for a rebound.

Its recent transactions, such as exits from Techem and Vishal Mega Mart, have already contributed to its 2024 earnings and are expected to provide a boost in 2025.

Its diversified mix of evergreen funds and institutional mandates further reduces its exposure to single-product risks, providing stability amid industry fluctuations.

Barclays’ outlook also notes that Partners’ forward price-to-earnings (P/E) ratio, though below historical peaks, offers headroom for growth.

The brokerage has set a new price target of CHF 1,470, reflecting anticipated improvements in market conditions and Partners’ ability to capitalize on them.

This projection comes alongside a forecast of increasing earnings per share, driven by higher performance fees and steady management fee growth.

Shares of the Swiss-based global private equity firm rose 1.8% at 06:15 ET (11:15 GMT).

This post appeared first on investing.com
Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    You May Also Like

    Latest News

    The Gateway Pundit, a far-right website, published a note from its editor on Saturday acknowledging that two election workers in Georgia did not engage...

    Latest News

    Sister Stephanie Schmidt had a hunch about what her fellow nuns would discuss over dinner at their Erie, Pennsylvania, monastery on Wednesday night. The...

    Investing

    JAKARTA (Reuters) -Indonesia has asked Alphabet (NASDAQ:GOOGL)’s Google and Apple (NASDAQ:AAPL) to block Chinese fast fashion e-commerce firm Temu in their application stores in...

    Latest News

    New majorities in Congress, particularly when the incoming party has a new leader, offer the rare chance for the institution to take a breath...



    Disclaimer: alivebusinessplan.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 alivebusinessplan.com